- •Preface
- •Contents
- •Pattern Approach for Lung Imaging
- •1: Nodule
- •Solitary Pulmonary Nodule (SPN), Solid
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Lung Cancer (Solid Adenocarcinoma)
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Carcinoid or Atypical Carcinoid
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •BALT Lymphoma
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Tuberculoma
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Hamartoma
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Sclerosing Hemangioma
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Ground-Glass Opacity Nodule
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Atypical Adenomatous Hyperplasia (AAH)
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Adenocarcinoma in Situ (AIS)
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Minimally Invasive Adenocarcinoma (MIA)
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •2: Mass
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Pulmonary Sarcoma
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Progressive Massive Fibrosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pulmonary Actinomycosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •3: Consolidation
- •Lobar Consolidation
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Lobar Pneumonia
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Invasive Mucinous Adenocarcinoma
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pulmonary Infarction
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Patchy and Nodular Consolidation
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Airway-Invasive Pulmonary Aspergillosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pulmonary Cryptococcosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •IgG4-Related Lung Disease
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Lymphomatoid Granulomatosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •4: Beaded Septum Sign
- •Diseases Causing the Sign
- •Distribution
- •Clinical Considerations
- •References
- •5: Comet Tail Sign
- •Diseases Causing the Sign
- •Distribution
- •Clinical Considerations
- •Rounded Atelectasis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •6: CT Halo Sign
- •Diseases Causing the Sign
- •Distribution
- •Clinical Considerations
- •Angioinvasive Pulmonary Aspergillosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Metastatic Hemorrhagic Tumors
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pulmonary Endometriosis with Catamenial Hemorrhage
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •7: Galaxy Sign
- •Diseases Causing the Sign
- •Distribution
- •Clinical Considerations
- •Galaxy Sign in Pulmonary Tuberculosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •8: Reversed Halo Sign
- •Diseases Causing the Sign
- •Distribution
- •Clinical Considerations
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pulmonary Mucormycosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Lymphomatoid Granulomatosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •9: Tree-in-Bud Sign
- •Diseases Causing the Sign
- •Distribution
- •Clinical Considerations
- •Aspiration Bronchiolitis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Foreign-Body-Induced Pulmonary Vasculitis (Cellulose and Talc Granulomatosis)
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •Diseases Causing the Sign
- •Distribution
- •Clinical Considerations
- •Bronchial Atresia
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Bronchial Tuberculosis and Mucoid Impaction
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Foreign-Body Aspiration
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Allergic Bronchopulmonary Aspergillosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •11: Lobar Atelectasis Sign
- •Disease Causing the Sign
- •Distribution
- •Clinical Considerations
- •Right Upper Lobar Atelectasis
- •Left Upper Lobar Atelectasis
- •Right Middle Lobar Atelectasis
- •Lower Lobar Atelectasis
- •References
- •Cavity
- •Diseases Causing the Cavity
- •Distribution
- •Clinical Considerations
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT-Pathology Comparisons
- •Patient Prognosis
- •Langerhans Cell Histiocytosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT-Pathology Comparisons
- •Patient Prognosis
- •Septic Pulmonary Embolism
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT-Pathology Comparisons
- •Patient Prognosis
- •Cavitary Pulmonary Tuberculosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT-Pathology Comparisons
- •Patient Prognosis
- •Paragonimiasis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT-Pathology Comparisons
- •Patient Prognosis
- •Cyst
- •Diseases Causing the Cyst
- •Distribution
- •Clinical Considerations
- •Blebs and Bullae
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT-Pathology Comparisons
- •Patient Prognosis
- •Pulmonary Sequestration
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT-Pathology Comparisons
- •Patient Prognosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT-Pathology Comparisons
- •Patient Prognosis
- •Intrapulmonary Bronchogenic Cyst
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT-Pathology Comparisons
- •Patient Prognosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT-Pathology Comparisons
- •Patient Prognosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT-Pathology Comparisons
- •Patient Prognosis
- •Traumatic Lung Cysts
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT-Pathology Comparisons
- •Patient Prognosis
- •References
- •Mosaic Attenuation
- •Diseases Causing the Mosaic Attenuation Pattern
- •Distribution
- •Clinical Considerations
- •Cystic Fibrosis
- •Pathology and Pathogenesis
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Constrictive Bronchiolitis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Chronic Pulmonary Thromboembolism
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Idiopathic Pulmonary Arterial Hypertension
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Airway Disease (Bronchiectasis and Bronchiolectasis)
- •Distribution
- •Clinical Considerations
- •Swyer-James-MacLeod Syndrome
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Dyskinetic Cilia Syndrome
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •14: Air-Crescent Sign
- •Diseases Causing the Sign
- •Distribution
- •Clinical Considerations
- •Aspergilloma
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Rasmussen’s Aneurysm
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •15: Signet Ring Sign
- •Diseases Causing the Sign
- •Distribution
- •Clinical Considerations
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •16: Interlobular Septal Thickening
- •Smooth Septal Thickening
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Pulmonary Edema
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT-Pathology Comparisons
- •Patient Prognosis
- •Niemann–Pick Disease
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT-Pathology Comparisons
- •Patient Prognosis
- •Nodular Septal Thickening
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Pulmonary Lymphangitic Carcinomatosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT-Pathology Comparisons
- •Patient Prognosis
- •References
- •17: Honeycombing
- •Honeycombing with Subpleural or Basal Predominance
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Asbestosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Honeycombing with Upper Lung Zone Predominance
- •Diseases Causing the Pattern and Distribution
- •Distribution
- •Clinical Considerations
- •Idiopathic Familial Pulmonary Fibrosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Chronic Hypersensitivity Pneumonia
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •End-stage Fibrotic Pulmonary Sarcoidosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •18: Small Nodules
- •Small Nodules with Centrilobular Distribution
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Mycoplasma Pneumoniae Pneumonia
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Diffuse Panbronchiolitis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Follicular Bronchiolitis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pulmonary Tumor Embolism
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Pneumoconiosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pulmonary Sarcoidosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pulmonary Alveoloseptal Amyloidosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Small Nodules with Random (Miliary) Distribution
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Miliary Tuberculosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Miliary Metastasis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •19: Multiple Nodular or Mass(-like) Pattern
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Pulmonary Metastasis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pulmonary Lymphoma
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Amyloidomas
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •ANCA-Associated Granulomatous Vasculitis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •Ground-Glass Opacity with Reticulation and Fibrosis
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Ground-Glass Opacity with Reticulation, but without Fibrosis (Crazy-Paving Appearance)
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Pneumocystis jirovecii Pneumonia
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Lipoid Pneumonia
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pulmonary Alveolar Proteinosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Mucinous Adenocarcinoma or Adenocarcinoma in Situ, Diffuse Form
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Desquamative Interstitial Pneumonia
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Ground-Glass Opacity without Reticulation, with Small Nodules
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Subacute Hypersensitivity Pneumonitis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Cytomegalovirus Pneumonia
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Diffuse Alveolar Hemorrhage
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Ground-Glass Opacity without Reticulation, Diffuse Distribution
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Acute Hypersensitivity Pneumonitis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Acute Eosinophilic Pneumonia
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •22: Consolidation
- •Consolidation with Subpleural or Patchy Distribution
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Cryptogenic Organizing Pneumonia
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Chronic Eosinophilic Pneumonia
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Churg–Strauss Syndrome
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Radiation Pneumonitis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Consolidation with Diffuse Distribution
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Viral Pneumonias
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Acute Interstitial Pneumonia
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Diffuse Alveolar Hemorrhage
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •23: Decreased Opacity with Cystic Walls
- •Cavities
- •Diseases Causing Cavities
- •Distribution
- •Clinical Considerations
- •Rheumatoid Lung Nodules
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Cavitary Metastasis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Cysts
- •Diseases Causing Multiple Cysts
- •Distribution
- •Clinical Considerations
- •Lymphangioleiomyomatosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Lymphocytic Interstitial Pneumonia
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Emphysema
- •Distribution
- •Clinical Considerations
- •Centrilobular Emphysema
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •Patient Prognosis
- •Paraseptal Emphysema
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •Patient Prognosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •Patient Prognosis
- •References
- •24: Decreased Opacity without Cystic Walls
- •Mosaic Attenuation, Vascular
- •Distribution
- •Clinical Considerations
- •Airway Diseases Causing Mosaic Attenuation
- •Distribution
- •Clinical Considerations
- •Asthma
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •Distribution
- •Clinical Considerations
- •Cystic Fibrosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •26: Pneumonia
- •Lobar Pneumonia
- •Bronchopneumonia
- •Interstitial Pneumonia
- •27: Drug-Induced Lung Disease
- •Interstitial Pneumonitis and Fibrosis
- •Eosinophilic Pneumonia
- •Cryptogenic Organizing Pneumonia
- •Diffuse Alveolar Damage
- •Hypersensitivity Pneumonia
- •References
- •Systemic Lupus Erythematosus (SLE)
- •Rheumatoid Arthritis (RA)
- •Progressive Systemic Sclerosis (PSS)
- •Sjögren’s Syndrome
- •Mixed Connective Tissue Disease
- •Ankylosing Spondylitis
- •References
218 |
21 Ground-Glass Opacity without Reticulation |
|
|
exposure, but recur after the next antigen contact. Tachypnea and diffuse Þne crackles are observed on physical examination.
accompanied by interlobular septal thickening and sometimes by consolidation or poorly deÞned small nodules [36, 41] (Figs. 21.7 and 21.8).
CT Findings |
CT–Pathology Comparisons |
The most common HRCT Þndings of acute HP consist of diffuse GGO and consolidation [38]. Centrilobular nodules also may be seen (Fig. 21.6).
Bilateral areas of GGO on HRCT correspond histopathologically to diffuse alveolar damage associated with interstitial and alveolar eosinophilia [42].
CT–Pathology Comparisons |
Patient Prognosis |
Diffuse GGO and consolidation may be due to cellular interstitial pneumonia or acute organizing pneumonia [27, 37].
Patient Prognosis
Early diagnosis and avoidance of antigen exposure are crucial in the management. Corticosteroids are recommended in severe respiratory impairment with hypoxemia. If the diagnosis is correctly and timely done, outcome is usually good.
Acute Eosinophilic Pneumonia
Pathology and Pathogenesis
AEP shows the features of diffuse alveolar damage in its exudative or organizing phases, coupled with a heavy interstitial inÞltrate. In its exudative phase, diffuse alveolar damage is characterized by hyaline membranes and in its organizing phase by interstitial Þbroblast proliferation, prominent alveolar epithelial regeneration, and organizing alveolar exudates [39].
Symptoms and Signs
Patients present with rapid onset of cough, tachypnea, and dyspnea of usually less than 7 days duration. Patients can progress from mild dyspnea to life-threatening respiratory failure in only a few hours. Fever is invariably present. Pleuritic chest pain and myalgia are common. Crackles are present in 80 % of patients. The disease is frequently misdiagnosed as severe community-acquired pneumonia [40].
CT Findings
The predominant patterns of parenchymal abnormality seen at HRCT are bilateral patchy areas of GGO, frequently
Approximately two-thirds of patients require mechanical ventilation, but they respond rapidly and completely to corticosteroids. Most patients have complete recovery with no long-term pulmonary symptoms [43].
References
1.Mueller-Mang C, Grosse C, Schmid K, Stiebellehner L, Bankier AA. What every radiologist should know about idiopathic interstitial pneumonias. Radiographics. 2007;27:595Ð615.
2.Lee KS, Kullnig P, Hartman TE, Muller NL. Cryptogenic organizing pneumonia: CT Þndings in 43 patients. AJR Am J Roentgenol. 1994;162:543Ð6.
3. Kim Y, Lee KS, Choi DC, Primack SL, Im JG. The spectrum of eosinophilic lung disease: radiologic Þndings. J Comput Assist Tomogr. 1997;21:920Ð30.
4. Min JH, Lee HY, Lim H, et al. Drug-induced interstitial lung disease in tyrosine kinase inhibitor therapy for non-small cell lung cancer: a review on current insight. Cancer Chemother Pharmacol. 2011;68:1099Ð109.
5. Kim EA, Lee KS, Johkoh T, et al. Interstitial lung diseases associated with collagen vascular diseases: radiologic and histopathologic Þndings. Radiographics. 2002;22 Spec No:S151Ð65.
6.Katzenstein AL, Fiorelli RF. NonspeciÞc interstitial pneumonia/ Þbrosis. Histologic features and clinical signiÞcance. Am J Surg Pathol. 1994;18:136Ð47.
7. Travis WD, Hunninghake G, King Jr TE, et al. Idiopathic nonspeciÞc interstitial pneumonia: report of an American Thoracic Society Project. Am J Respir Crit Care Med. 2008;177:1338Ð47.
8. Kligerman SJ, Groshong S, Brown KK, Lynch DA. NonspeciÞc interstitial pneumonia: radiologic, clinical, and pathologic considerations. Radiographics. 2009;29:73Ð87.
9. Park IN, Kim DS, Shim TS, et al. Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary Þbrosis. Chest. 2007;132:214Ð20.
10.Tsubamoto M, Muller NL, Johkoh T, et al. Pathologic subgroups of nonspeciÞc interstitial pneumonia: differential diagnosis from other idiopathic interstitial pneumonias on high-resolution computed tomography. J Comput Assist Tomogr. 2005;29:793Ð800.
11.Kim TS, Lee KS, Chung MP, et al. NonspeciÞc interstitial pneumonia with Þbrosis: high-resolution CT and pathologic Þndings. AJR Am J Roentgenol. 1998;171:1645Ð50.
12.Yousem SA, Colby TV, Gaensler EA. Respiratory bronchiolitisassociated interstitial lung disease and its relationship to desquamative interstitial pneumonia. Mayo Clin Proc. 1989;64:1373Ð80.
13.Vassallo R. Diffuse lung diseases in cigarette smokers. Semin Respir Crit Care Med. 2012;33:533Ð42.
References |
219 |
|
|
14.Hartman TE, Primack SL, Swensen SJ, Hansell D, McGuinness G, Muller NL. Desquamative interstitial pneumonia: thin-section CT Þndings in 22 patients. Radiology. 1993;187:787Ð90.
15.Hidalgo A, Franquet T, Gimenez A, Bordes R, Pineda R, Madrid M. Smoking-related interstitial lung diseases: radiologic-patho- logic correlation. Eur Radiol. 2006;16:2463Ð70.
16.Okada F, Ando Y, Yoshitake S, et al. Clinical/pathologic correlations in 553 patients with primary centrilobular Þndings on highresolution CT scan of the thorax. Chest. 2007;132:1939Ð48.
17.Hansell DM, Wells AU, Padley SP, Muller NL. Hypersensitivity pneumonitis: correlation of individual CT patterns with functional abnormalities. Radiology. 1996;199:123Ð8.
18.Moon JH, Kim EA, Lee KS, Kim TS, Jung KJ, Song JH. Cytomegalovirus pneumonia: high-resolution CT Þndings in ten nonAIDS immunocompromised patients. Korean J Radiol. 2000;1:73Ð8.
19.Franquet T, Lee KS, Muller NL. Thin-section CT Þndings in 32 immunocompromised patients with cytomegalovirus pneumonia who do not have AIDS. AJR Am J Roentgenol. 2003;181:1059Ð63.
20.Chung MP, Yi CA, Lee HY, Han J, Lee KS. Imaging of pulmonary vasculitis. Radiology. 2010;255:322Ð41.
21.Morell F, Roger A, Reyes L, Cruz MJ, Murio C, Munoz X. Bird fancierÕs lung: a series of 86 patients. Medicine (Baltimore). 2008;87:110Ð30.
22.Lara AR, Schwarz MI. Diffuse alveolar hemorrhage. Chest. 2010;137:1164Ð71.
23.Selman M, Pardo A, King Jr TE. Hypersensitivity pneumonitis: insights in diagnosis and pathobiology. Am J Respir Crit Care Med. 2012;186:314Ð24.
24.Selman M, Buendia-Roldan I. Immunopathology, diagnosis, and management of hypersensitivity pneumonitis. Semin Respir Crit Care Med. 2012;33:543Ð54.
25.Small JH, Flower CD, Traill ZC, Gleeson FV. Air-trapping in extrinsic allergic alveolitis on computed tomography. Clin Radiol. 1996;51:684Ð8.
26. Franquet T, Hansell DM, Senbanjo T, Remy-Jardin M, Muller NL. Lung cysts in subacute hypersensitivity pneumonitis. J Comput Assist Tomogr. 2003;27:475Ð8.
27.Silva CI, Churg A, Muller NL. Hypersensitivity pneumonitis: spectrum of high-resolution CT and pathologic Þndings. AJR Am J Roentgenol. 2007;188:334Ð44.
28.Wallace JM, Hannah J. Cytomegalovirus pneumonitis in patients with AIDS. Findings in an autopsy series. Chest. 1987;92:198Ð203.
29. de Maar EF, Verschuuren EA, Harmsen MC, The TH, van Son WJ. Pulmonary involvement during cytomegalovirus infection in immunosuppressed patients. Transpl Infect Dis. 2003;5: 112Ð20.
30. Lombard CM, Colby TV, Elliott CG. Surgical pathology of the lung in anti-basement membrane antibody-associated GoodpastureÕs syndrome. Hum Pathol. 1989;20:445Ð51.
31.Primack SL, Miller RR, Muller NL. Diffuse pulmonary hemorrhage: clinical, pathologic, and imaging features. AJR Am J Roentgenol. 1995;164:295Ð300.
32.Cheah FK, Sheppard MN, Hansell DM. Computed tomography of diffuse pulmonary haemorrhage with pathological correlation. Clin Radiol. 1993;48:89Ð93.
33.Blatman KH, Grammer LC. Chapter 19: Hypersensitivity pneumonitis. Allergy Asthma Proc. 2012;33 Suppl 1:S64Ð6.
34.Catherinot E, Lanternier F, Bougnoux ME, Lecuit M, Couderc LJ, Lortholary O. Pneumocystis jirovecii pneumonia. Infect Dis Clin North Am. 2010;24:107Ð38.
35.Allen JN, Pacht ER, Gadek JE, Davis WB. Acute eosinophilic pneumonia as a reversible cause of noninfectious respiratory failure. N Engl J Med. 1989;321:569Ð74.
36.Cheon JE, Lee KS, Jung GS, Chung MH, Cho YD. Acute eosinophilic pneumonia: radiographic and CT Þndings in six patients. AJR Am J Roentgenol. 1996;167:1195Ð9.
37. Lacasse Y, Girard M, Cormier Y. Recent advances in hypersensitivity pneumonitis. Chest. 2012;142:208Ð17.
38.Silver SF, Muller NL, Miller RR, Lefcoe MS. Hypersensitivity pneumonitis: evaluation with CT. Radiology. 1989;173:441Ð5.
39.Tazelaar HD, Linz LJ, Colby TV, Myers JL, Limper AH. Acute eosinophilic pneumonia: histopathologic Þndings in nine patients. Am J Respir Crit Care Med. 1997;155:296Ð302.
40.Rhee CK, Min KH, Yim NY, et al. Clinical characteristics and corticosteroid treatment of acute eosinophilic pneumonia. Eur Respir J. 2013;41:402Ð9.
41.King MA, Pope-Harman AL, Allen JN, Christoforidis GA, Christoforidis AJ. Acute eosinophilic pneumonia: radiologic and clinical features. Radiology. 1997;203:715Ð9.
42.Jeong YJ, Kim KI, Seo IJ, et al. Eosinophilic lung diseases: a clinical, radiologic, and pathologic overview. Radiographics. 2007;27:617Ð37; discussion 637Ð9.
43.Allen J. Acute eosinophilic pneumonia. Semin Respir Crit Care Med. 2006;27:142Ð7.